Osteoimmunology - The hidden immune regulation of bone

Autoimmunity Reviews

Volumn 8, Issue 3, 2009, Pages 250-255

  J , Caetano Lopes ^a   H , Canhão ^a,b   J E , Fonseca ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Adipose tissue; Bone; Immune system; Osteoimmunoendocrinology; Osteoimmunology

Indexed keywords

ADIPOCYTOKINE; CHEMOKINE; COLONY STIMULATING FACTOR 1; CYTOKINE; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

ADIPOSE TISSUE; BONE STRUCTURE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL INTERACTION; CYTOKINE RELEASE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SKELETON; T LYMPHOCYTE;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE RESORPTION; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; CYTOSKELETON; HUMANS; IMMUNE SYSTEM; MACROPHAGE COLONY-STIMULATING FACTOR; OSTEOBLASTS; OSTEOCLASTS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION;

EID: 58149459512     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.07.038     Document Type: Review

References (38)

1. Arron J.R., and Choi Y. Bone versus immune system. Nature 408 (2000) 535-536
2. Wong B.R., Josien R., and Choi Y. TRANCE is a TNF family member that regulates dendritic cell and osteoclast function. J Leukoc Biol 65 (1999) 715-724
3. Saidenberg-Kermanac'h N., Cohen-Solal M., Bessis N., De Vernejoul M.C., and Boissier M.C. Role for osteoprotegerin in rheumatoid inflammation. Jt Bone Spine 71 (2004) 9-13
4. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7 (2007) 292-304
5. Asagiri M., and Takayanagi H. The molecular understanding of osteoclast differentiation. Bone 40 (2007) 251-264
6. Kobayashi N., Kadono Y., Naito A., Matsumoto K., Yamamoto T., Tanaka S., et al. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. Embo J 20 (2001) 1271-1280
7. Wu H., and Arron J.R. TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. Bioessays 25 (2003) 1096-1105
8. Mundy G.R., and Elefteriou F. Boning up on ephrin signaling. Cell 126 (2006) 441-443
9. Zhao C., Irie N., Takada Y., Shimoda K., Miyamoto T., Nishiwaki T., et al. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 4 (2006) 111-121
10. Pasquale E.B. Eph-ephrin bidirectional signaling in physiology and disease. Cell 133 (2008) 38-52
11. Herman S., Kronke G., and Schett G. Molecular mechanisms of inflammatory bone damage: emerging targets for therapy. Trends Mol Med 14 (2008) 245-253
12. Datta H.K., Ng W.F., Walker J.A., Tuck S.P., and Varanasi S.S. The cell biology of bone metabolism. J Clin Pathol 61 (2008) 577-587
13. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203 (2006) 2673-2682
14. Furuzawa-Carballeda J., Vargas-Rojas M.I., and Cabral A.R. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6 (2007) 169-175
15. David J.P. Osteoimmunology: a view from the bone. Adv Immunol 95 (2007) 149-165
16. Kim Y.G., Lee C.K., Nah S.S., Mun S.H., Yoo B., and Moon H.B. Human CD4 + CD25 +regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem Biophys Res Commun 357 (2007) 1046-1052
17. Kelchtermans H., Geboes L., Mitera T., Huskens D., Leclercq G., and Matthys P. Activated CD4 + CD25 + regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis. Ann Rheum Dis (2008)
18. Askenasy N., Kaminitz A., and Yarkoni S. Mechanisms of T regulatory cell function. Autoimmun Rev 7 (2008) 370-375
19. Lan R.Y., Ansari A.A., Lian Z.X., and Gershwin M.E. Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev 4 (2005) 351-363
20. Koga T., Inui M., Inoue K., Kim S., Suematsu A., Kobayashi E., et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428 (2004) 758-763
21. Bar-Shavit Z. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators. Autoimmunity 41 (2008) 195-203
22. Walsh M.C., Kim N., Kadono Y., Rho J., Lee S.Y., Lorenzo J., et al. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 24 (2006) 33-63
23. Hurst J., and von Landenberg P. Toll-like receptors and autoimmunity. Autoimmun Rev 7 (2008) 204-208
24. Lago F., Dieguez C., Gomez-Reino J., and Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 3 (2007) 716-724
25. Bernotiene E., Palmer G., and Gabay C. The role of leptin in innate and adaptive immune responses. Arthritis Res Ther 8 (2006) 217
26. Caetano-Lopes J., Canhao H., and Fonseca J.E. Osteoblasts and bone formation. Acta Reumatol Port 32 (2007) 103-110
27. Gordeladze J.O., Drevon C.A., Syversen U., and Reseland J.E. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 85 (2002) 825-836
28. Rosen C.J., and Bouxsein M.L. Mechanisms of disease: is osteoporosis the obesity of bone?. Nat Clin Pract Rheumatol 2 (2006) 35-43
29. Gunther T., and Schule R. Fat or bone? A non-canonical decision. Nat Cell Biol 9 (2007) 1229-1231
30. Takada I., Mihara M., Suzawa M., Ohtake F., Kobayashi S., Igarashi M., et al. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol 9 (2007) 1273-1285
31. Jiang C., Ting A.T., and Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391 (1998) 82-86
32. Straus D.S., and Glass C.K. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 28 (2007) 551-558
33. Wahli W. PPAR gamma: ally and foe in bone metabolism. Cell Metab 7 (2008) 188-190
34. Wan Y., Chong L.W., and Evans R.M. PPAR-gamma regulates osteoclastogenesis in mice. Nat Med 13 (2007) 1496-1503
35. Kallen C.B., and Lazar M.A. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A 93 (1996) 5793-5796
36. Fonseca J.E., Cortez-Dias N., Francisco A., Sobral M., Canhao H., Resende C., et al. Inflammatory cell infiltrate and RANKL/OPG expression in rheumatoid synovium: comparison with other inflammatory arthropathies and correlation with outcome. Clin Exp Rheumatol 23 (2005) 185-192
37. Nery AM, Caetano-Lopes J, Henriques R, Canhão H, Duarte J, Amaral, PM et al. Chronic arthritis induces quantitative and qualitative bone disturbances leading to compromised biomechanical properties (submitted for publication).
38. Del Fattore A., Teti A., and Rucci N. Osteoclast receptors and signaling. Arch Biochem Biophys 473 (2008) 147-160